Wellington Management Group LLP Decreases Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Wellington Management Group LLP lowered its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 679,603 shares of the company's stock after selling 10,836 shares during the quarter. Wellington Management Group LLP owned about 0.78% of HealthEquity worth $65,208,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Barclays PLC increased its holdings in HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company's stock worth $13,628,000 after purchasing an additional 112,667 shares during the period. Nisa Investment Advisors LLC increased its position in HealthEquity by 8.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 3,719 shares of the company's stock valued at $357,000 after purchasing an additional 299 shares during the period. Janney Montgomery Scott LLC increased its position in HealthEquity by 8.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 5,352 shares of the company's stock valued at $514,000 after purchasing an additional 420 shares during the period. Exchange Traded Concepts LLC increased its position in HealthEquity by 2.6% during the 4th quarter. Exchange Traded Concepts LLC now owns 9,813 shares of the company's stock valued at $942,000 after purchasing an additional 245 shares during the period. Finally, KBC Group NV increased its position in HealthEquity by 56.7% during the 4th quarter. KBC Group NV now owns 3,860 shares of the company's stock valued at $370,000 after purchasing an additional 1,397 shares during the period. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Stock Performance

NASDAQ:HQY traded up $0.13 during mid-day trading on Friday, hitting $101.11. The company's stock had a trading volume of 960,737 shares, compared to its average volume of 811,062. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a market cap of $8.75 billion, a price-to-earnings ratio of 92.76, a PEG ratio of 1.60 and a beta of 0.45. The business's fifty day moving average is $89.41 and its two-hundred day moving average is $97.46.

Wall Street Analyst Weigh In

HQY has been the topic of several research reports. The Goldman Sachs Group cut their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price target for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Barrington Research reiterated an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. Royal Bank of Canada began coverage on shares of HealthEquity in a research report on Thursday, May 22nd. They set an "outperform" rating and a $112.00 target price on the stock. Finally, KeyCorp dropped their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, HealthEquity currently has a consensus rating of "Buy" and an average target price of $112.33.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This trade represents a 6.34% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.50% of the company's stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.